Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1820 | 2403 | 36.2 | 74% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OSELTAMIVIR | Author keyword | 294 | 60% | 13% | 324 |
2 | NEURAMINIDASE INHIBITOR | Author keyword | 205 | 79% | 5% | 130 |
3 | ZANAMIVIR | Author keyword | 171 | 71% | 6% | 137 |
4 | NEURAMINIDASE INHIBITORS | Author keyword | 156 | 69% | 6% | 134 |
5 | LANINAMIVIR | Author keyword | 107 | 97% | 1% | 31 |
6 | PERAMIVIR | Author keyword | 90 | 82% | 2% | 53 |
7 | TAMIFLU | Author keyword | 83 | 74% | 3% | 62 |
8 | OSELTAMIVIR RESISTANCE | Author keyword | 74 | 84% | 2% | 41 |
9 | H275Y | Author keyword | 45 | 94% | 1% | 16 |
10 | NEURAMINIDASE | Author keyword | 39 | 21% | 7% | 163 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OSELTAMIVIR | 294 | 60% | 13% | 324 | Search OSELTAMIVIR | Search OSELTAMIVIR |
2 | NEURAMINIDASE INHIBITOR | 205 | 79% | 5% | 130 | Search NEURAMINIDASE+INHIBITOR | Search NEURAMINIDASE+INHIBITOR |
3 | ZANAMIVIR | 171 | 71% | 6% | 137 | Search ZANAMIVIR | Search ZANAMIVIR |
4 | NEURAMINIDASE INHIBITORS | 156 | 69% | 6% | 134 | Search NEURAMINIDASE+INHIBITORS | Search NEURAMINIDASE+INHIBITORS |
5 | LANINAMIVIR | 107 | 97% | 1% | 31 | Search LANINAMIVIR | Search LANINAMIVIR |
6 | PERAMIVIR | 90 | 82% | 2% | 53 | Search PERAMIVIR | Search PERAMIVIR |
7 | TAMIFLU | 83 | 74% | 3% | 62 | Search TAMIFLU | Search TAMIFLU |
8 | OSELTAMIVIR RESISTANCE | 74 | 84% | 2% | 41 | Search OSELTAMIVIR+RESISTANCE | Search OSELTAMIVIR+RESISTANCE |
9 | H275Y | 45 | 94% | 1% | 16 | Search H275Y | Search H275Y |
10 | NEURAMINIDASE | 39 | 21% | 7% | 163 | Search NEURAMINIDASE | Search NEURAMINIDASE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ZANAMIVIR | 307 | 72% | 10% | 244 |
2 | OSELTAMIVIR | 221 | 47% | 15% | 353 |
3 | NEURAMINIDASE INHIBITORS | 191 | 52% | 11% | 260 |
4 | NEURAMINIDASE INHIBITOR OSELTAMIVIR | 144 | 63% | 6% | 147 |
5 | POTENT ANTIINFLUENZA ACTIVITY | 126 | 86% | 3% | 65 |
6 | RWJ 270201 | 123 | 91% | 2% | 51 |
7 | VIRUS NEURAMINIDASE | 120 | 69% | 4% | 103 |
8 | INHALED ZANAMIVIR | 109 | 81% | 3% | 65 |
9 | GG167 | 107 | 97% | 1% | 31 |
10 | AH1N1 VIRUSES | 93 | 87% | 2% | 46 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Influenza virus resistance to neuraminidase inhibitors | 2013 | 60 | 112 | 99% |
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives | 2012 | 53 | 64 | 91% |
Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods | 2012 | 45 | 100 | 92% |
Antivirals for Treatment of Influenza A Systematic Review and Meta-analysis of Observational Studies | 2012 | 70 | 65 | 54% |
Favipiravir (T-705), a novel viral RNA polymerase inhibitor | 2013 | 50 | 25 | 48% |
Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance | 2013 | 21 | 89 | 97% |
Drug therapy - Neuraminidase inhibitors for influenza | 2005 | 514 | 49 | 78% |
Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009-2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients | 2013 | 49 | 22 | 45% |
Influenza neuraminidase: A druggable target for natural products | 2012 | 43 | 162 | 60% |
Roche perspectives on Tamiflu | 2015 | 1 | 15 | 87% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VIRUS SURVEILLANCE DIAG BRANCH | 17 | 68% | 0.6% | 15 |
2 | ABORATING SURVEILLANCE EPIDEMIOL CONTRO | 6 | 80% | 0.2% | 4 |
3 | ABORATING REFERENCE INFLUENZA | 4 | 23% | 0.6% | 14 |
4 | CORP SAFETY HLTH ENVIRONM PROTECT | 3 | 100% | 0.1% | 3 |
5 | J AN PHYS ASSOC | 3 | 100% | 0.1% | 3 |
6 | PETIT SCI 788 | 3 | 100% | 0.1% | 3 |
7 | EPIDEMIOL VIROL | 3 | 35% | 0.3% | 7 |
8 | 47D | 3 | 60% | 0.1% | 3 |
9 | CHEMOTHER Y INFECT DIS | 3 | 60% | 0.1% | 3 |
10 | ICS UNIDO | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000135679 | M2 CHANNEL//M2 PROTON CHANNEL//M2 PROTEIN |
2 | 0.0000128806 | RIMANTADINE//AMANTADINE HCL//MEMANTINE HYDROCHLORIDE |
3 | 0.0000123145 | HEMAGGLUTININ//ANTIGENIC DRIFT//D222G |
4 | 0.0000122832 | H1N1//INFLUENZA A H1N1//H1N1 SUBTYPE |
5 | 0.0000091463 | RAPID INFLUENZA DIAGNOSTIC TEST//RESPIRATORY VIRUSES//RAPID ANTIGEN TEST |
6 | 0.0000084563 | AFFINITY MASS SPECTROMETRY//PEPTIDE CHIP ANALYSIS//PROTEOLYTIC EPITOPE EXCISION |
7 | 0.0000078331 | LIVE ATTENUATED INFLUENZA VACCINE//INFLUENZA VACCINE//INFLUENZA |
8 | 0.0000077090 | INFLUENZACHINESE INFLUENZA//IMMUNOL PATHOGENESIS BRANCH//INT INFECT IMMUN |
9 | 0.0000071418 | DAS181//PARAINFLUENZA//ALBERTA TRANSPLANT SCI |
10 | 0.0000069021 | PANDEMIC//SCHOOL CLOSURE//PANDEMIC INFLUENZA |